Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs.

Translational oncology·2018

Same author

Leprosy Associated with Atypical Cutaneous Leishmaniasis in Nicaragua and Honduras.

The American journal of tropical medicine and hygiene·2017

Same author

Coley's Lessons Remembered: Augmenting Mistletoe Therapy.

Integrative cancer therapies·2016

Same author

Ancient Retrovirus Targeted by Engineered T Cells in Melanoma--Letter.

Clinical cancer research : an official journal of the American Association for Cancer Research·2015

Same author

Vaccination, infection, and the risk for multiple sclerosis.

JAMA neurology·2015

Same author

The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.

BMC cancer·2014

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

Pathogen-associated molecular pattern in cancer immunotherapy.

Uwe Hobohm¹, John L Stanford, John M Grange

¹University of Applied Sciences, Bioinformatics, Wiesenstrasse 14, D-35390 Giessen, Germany. uwe.hobohm@tg.fh-giessen.de

Critical Reviews in Immunology

|June 11, 2008

Summary

This summary is machine-generated.

Pathogen-associated molecular patterns (PAMP) exposure via infection or vaccination shows promise for preventing and treating cancer. Further research is needed to fully utilize PAMP for cancer therapy and prophylaxis.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Experiment Videos

Last Updated: Jul 4, 2026

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Area of Science:

Oncology
Immunology
Infectious Disease

Background:

Emerging evidence suggests pathogen-associated molecular patterns (PAMP) exposure may influence neoplastic diseases.
Observations span epidemiological data, spontaneous cancer regressions, clinical studies, and tumor immunology.

Purpose of the Study:

To summarize existing clinical, epidemiological, and experimental data on PAMP's role in cancer.
To discuss the potential of PAMP for cancer prophylaxis and therapy.

Main Methods:

Review and synthesis of clinical data.
Analysis of epidemiological studies.
Examination of experimental and tumor immunology findings.

Main Results:

PAMP exposure, through infection or vaccination, demonstrates beneficial effects in neoplastic diseases.
These effects are observed both prophylactically and therapeutically.
The full therapeutic and prophylactic potential of PAMP in cancer remains largely untapped.

Conclusions:

PAMP represent a promising avenue for novel cancer prevention and treatment strategies.
Harnessing PAMP could significantly advance cancer care.
Further investigation is warranted to optimize PAMP-based cancer interventions.